| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |